China News Service, Shenzhen, November 12 (Reporter Zheng Xiaohong) The first domestic academic conference on "Synthetic Immunology"-Frontiers of Synthetic Immunology Forum, held in Shenzhen on the 12th to discuss tumor immunotherapy, synthetic bacterial therapy and other fields The latest research results and future development directions.
The forum was organized by Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences (hereinafter referred to as "Shenzhen Advanced Institute"), Shenzhen University of Technology (in preparation), School of Engineering Biology, Chinese Academy of Sciences, Shenzhen Institute of Synthetic Biology Innovation, and Key Experiments of Quantitative Engineering Biology, Chinese Academy of Sciences Jointly organized by the room.
According to reports, synthetic immunology adheres to the principle of basic research and the transformation of results, breaks through the traditional research thinking of life sciences, and integrates synthetic technology and immune technology. It is a new discipline aimed at the frontier of science and technology and a new direction of life science research.
The experts at the conference shared the latest research progress and put forward scientific thinking, which provided unlimited possibilities for the future development of synthetic immunology.
At the meeting, experts introduced the TCR molecular design based on T cells for immunotherapy against tumors and viral infections, and proposed a new concept-STAR-T cells; introduced manganese adjuvants and tumor "manganese immunotherapy", and proposed The use of manganese to treat tumors can improve the anti-tumor effect of immune cells, reduce the size of tumors, and prolong the survival time of patients. The latest research results such as synthetic immunology based on CAR molecules are introduced.
As the first domestic academic conference with the theme of "synthetic immunology", this conference aims to provide a communication platform for experts in the field to discuss how to do a good job in the cross-combination of synthesis and immunity, and how to use the basic theories of synthetic immunology to guide synthetic biology Key issues such as the rational design of the system provide suggestions for promoting the development of domestic synthetic immunology.
Nearly 20 well-known experts and scholars in this field at home and abroad, including Tian Zhigang, academician of the Chinese Academy of Engineering and director of the Synthetic Immunology Research Center of Shenzhen Institute of Synthetic Biology Innovation, attended this forum, and more than 8,000 online and offline scholars who are passionate about synthetic immunology participated This forum.
(Finish)